The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of tyrosine kinase inhibitors after immunotherapy in advanced hepatocellular carcinoma: A multi-center study.
 
Thomas Yau
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb
 
Joycelyn Jie Xin Lee
Consulting or Advisory Role - Bayer; Ipsen
Research Funding - Bayer (Inst)
 
Jeffrey Sum Lung Wong
No Relationships to Disclose
 
Vikki Tang
Stock and Other Ownership Interests - Bristol-Myers Squibb; Exelixis
 
Jess Chan
No Relationships to Disclose
 
Gin Wai Kwok
No Relationships to Disclose
 
Joanne Wing Yan Chiu
No Relationships to Disclose
 
Roland Ching-Yu Leung
No Relationships to Disclose
 
Bryan Li
No Relationships to Disclose
 
Wing Yan Josephine Tsang
No Relationships to Disclose
 
Tan To Cheung
No Relationships to Disclose
 
SuPin Choo
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
Honoraria - AstraZeneca; BMS; Eisai; Ipsen; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD Oncology; Roche; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Taiho Pharmaceutical
 
Wai Meng David Tai
Honoraria - Bristol-Myers Squibb; Eisai
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen; Roche
Research Funding - Bristol-Myers Squibb; Novartis; Sirtex Medical